Kategorien
-
Adhesives
6
Amines
115
Amino Acids
210
Analytical Reagents
752
Antibiotics
275
Bioactive Small Molecules
806
Aroma Chemicals
246
Biochemicals
1157
Boronic Acids
4
Buffers
105
Building Blocks
2191
Carbohydrates
193
Catalysts
119
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
63
Diagnostic Raw Materials
272
Flavours and Fragrance Materials
237
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
32
HPLC Reagents
8
Imidazoles
19
Indoles
48
Inorganic Chemicals
359
Ion-Pair Reagents
22
Ligands
81
Organics
1648
Oxazoles
3
Peptide Reagents
101
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
68
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
894
Salts
310
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
324
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
14
Water Analysis
12
Alizarin (C.I. 58000)
(29169958 | 72-48-0)
CAS: | 72-48-0 |
---|---|
Molekularformel: | C14H8O4 |
Molekulargewicht: | 240.21 |
Verfügbarkeit: | Auf Lager |
---|---|
Downloads: | | |
Für dieses Produkt wird ein Gefahrstoffzuschlag erhoben. Der genaue Betrag wird von unserem Verkaufsteam bestätigt.
29169958-100g | 100g | £42.60 | |
Bulk Menge |
29169958-100g | 100g | €59.70 | |
Bulk Menge |
29169958-100g | 100g | $63.90 | |
Bulk Menge |
Sicherheitsdatenblatt
Analysezertifikat
Produktbeschreibung
Product Code | 29169958 | ||||
Product Name | Alizarin (C.I. 58000) | ||||
Categories | Stains & Indicators | ||||
CAS | 72-48-0 | ||||
Molecular Formula | C14H8O4 | ||||
Molecular Weight | 240.21 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 32129000 |
Produktspezifikation
Grade | Industrial | ||||
Molecular Weight | 240.213 | ||||
Appearance | Brown to orange/ yellow powder | ||||
Ignition residue | 2.0% max | ||||
Indicator | pH 5.8 to 7.2 | ||||
For research use only, not for human use | research use only, not for human use |
Sicherheitsinformation
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|